Impact of a 30-day post-discharge telepharmacy program on hospital readmission, medication discrepancies, adherence and patient satisfaction in Jordan

Impact of a 30-day post-discharge telepharmacy program on hospital readmission, medication discrepancies, adherence and patient satisfaction in Jordan: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN83948874

Enrollment

312

Registered

2026-02-26

Start date

2025-07-01

Completion date

Unknown

Last updated

2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Telepharmacy during hospital discharge to prevent medication discrepancies, inadequate follow-up care, and early adverse drug events contributing to non-adherence and avoidable readmissions. Other

Interventions

Recruitment and Enrollment Procedures Potentially eligible patients were screened near the time of discharge using the ward discharge list. Sampling continued iteratively until the desired sample size

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged =18 years 2. Discharged home from an adult medical and surgical wards 3. Prescribed =1 chronic medication at discharge 4. Possess a functional mobile phone with WhatsApp® capability (personal or caregiver’s) 5. Written informed consent for follow-up contacts

Exclusion criteria

Exclusion criteria: 1. Discharged to a long-term care facility or another hospital (Referral) 2. Severe cognitive impairment or hearing deficits that precluded telephone/video communication (unless a dedicated caregiver was available) 3. No reliable phone access for the 30-day follow-up period 4. Refused to give consent

Countries

Jordan

Contacts

Public ContactDerar Abdel-Qader

d.balawi@igec.com.au+962 7 9556 3555

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026